Decentralized demand Position Atlas as a provider of rapid near-patient and Point-of-Care infectious disease diagnostics to capitalize on the shift from hub testing to spokes and decentralized workflows.

Rapid, cost-effective Highlight io platform capabilities such as 30-minute sample-answer time, high accuracy, and low-cost testing to win opportunities with clinics, urgent care centers, and rural health providers seeking fast, affordable diagnostics.

Clinical partnerships Target collaborations with healthcare networks, ambulatory clinics, and hospital systems that require scalable POC solutions, leveraging existing investor credibility from Novartis Venture Fund and Johnson & Johnson Innovation to open doors.

Global coverage Leverage Bat-based presence in Boston and Bath to pursue multi-region deployments, offering cross-border support, regulatory navigation, and localized service for international customers.

Growth enablers Focus on expanding sales through demonstrating a portable, user-friendly platform with broad infectious disease coverage to align with workforce shortages and the push for point-of-care testing adoption in diverse settings.